This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C

NCT01528735 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: BI 207127 NA
DRUG: peginterferon
DRUG: Ribavirin
DRUG: Ribavirin
DRUG: BI 207127 NA
DRUG: BI 201335 NA
DRUG: BI 201335 NA
DRUG: peginterferon

Sponsor

Boehringer Ingelheim